Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

Suchergebnisse filtern
Datenmodelle auswählen

Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

144 Suchergebnisse.

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 28.06.17 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, LASER ADMINISTRATION STUDY EYE

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

- 11.06.17 - 1 Formular, 3 Itemgruppen, 12 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12), Procedure

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Prior Ocular Therapies And Procedures Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g - Prior Ocular Therapies And Procedures Screening

- 21.03.18 - 1 Formular, 1 Itemgruppe, 11 Datenelemente, 1 Sprache

Itemgruppe: Therapy diabetes mellitus

Study part: Prior Ocular Therapies And Procedures Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Prior Ocular Therapies And Procedures Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Prior Ocular Therapies And Procedures Screening

- 20.03.18 - 1 Formular, 1 Itemgruppe, 11 Datenelemente, 1 Sprache

Itemgruppe: Therapy diabetes mellitus

Study part: Prior Ocular Therapies And Procedures Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Prior Therapies for RVO Screening Ranibizumab Macular Edema Secondary To Branch Retinal Vein Occlusion FVF4165g - Prior Therapies for RVO Screening

- 18.03.18 - 1 Formular, 1 Itemgruppe, 11 Datenelemente, 1 Sprache

Itemgruppe: Therapy Age related macular degeneration

Study part: Prior Therapies for RVO Screening. A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection Compared With Sham In Subjects with Macular Edema Secondary To Branch Retinal Vein Occlusion.

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 17) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache

Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 17)

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.